Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Huddart

Showing results (41-50 of 111) with videos related to

Pageof 12
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2015
Defining a New Prognostic Index for Stage I Nonseminomatous Germ Cell Tumors Using CXCL12 Expression and Proportion of Embryonal CarcinomaDuncan C Gilbert, Reem Al-Saadi, Khin Thway, et al.
International Journal of Radiation Oncology, Biology, Physics|January 23, 2010
Expression of Bcl-2, p53, and MDM2 in localized prostate cancer with respect to the outcome of radical radiotherapy dose escalationRoy Vergis, Catherine M Corbishley, Karen Thomas, et al.
European Urology|December 9, 2020
Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by (Chemo)radiotherapy in the BC2001 TrialSyed A Hussain, Nuria Porta, Emma Hall, et al.
European Urology|February 14, 2018
Large-scale Sequencing of Testicular Germ Cell Tumour (TGCT) Cases Excludes Major TGCT Predisposition GeneKevin Litchfield, Chey Loveday, Max Levy, et al.
The New England Journal of Medicine|September 9, 2005
Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomasMichael Cullen, Neil Steven, Lucinda Billingham, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 4, 2015
The potential of MRI-guided online adaptive re-optimisation in radiotherapy of urinary bladder cancerAnne Vestergaard, Shaista Hafeez, Ludvig P Muren, et al.
Clinical Genitourinary Cancer|August 18, 2018
Salvage Chemotherapy With Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin for Relapsed Germ Cell CancerHayley S McKenzie, Graham Mead, Robert Huddart, et al.
Oncogene|October 19, 2004
Defining minimum genomic regions of imbalance involved in testicular germ cell tumors of adolescents and adults through genome wide microarray analysis of cDNA clonesAlan McIntyre, Brenda Summersgill, Osman Jafer, et al.
Clinical and Translational Radiation Oncology|June 14, 2024
Weekly ultra-hypofractionated radiotherapy in localised prostate cancerNora Sundahl, Douglas Brand, Chris Parker, et al.
BJU International|April 27, 2020
A randomised Phase II trial of carboplatin and gemcitabine ± vandetanib in first-line treatment of patients with advanced urothelial cell cancer not suitable to receive cisplatinRobert Jones, Simon Crabb, John Chester, et al.
Pageof 12

Showing results (41-50 of 111) with videos related to

Sort By:
Pageof 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2015
Defining a New Prognostic Index for Stage I Nonseminomatous Germ Cell Tumors Using CXCL12 Expression and Proportion of Embryonal CarcinomaDuncan C Gilbert, Reem Al-Saadi, Khin Thway, et al.
International Journal of Radiation Oncology, Biology, Physics|January 23, 2010
Expression of Bcl-2, p53, and MDM2 in localized prostate cancer with respect to the outcome of radical radiotherapy dose escalationRoy Vergis, Catherine M Corbishley, Karen Thomas, et al.
European Urology|December 9, 2020
Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by (Chemo)radiotherapy in the BC2001 TrialSyed A Hussain, Nuria Porta, Emma Hall, et al.
European Urology|February 14, 2018
Large-scale Sequencing of Testicular Germ Cell Tumour (TGCT) Cases Excludes Major TGCT Predisposition GeneKevin Litchfield, Chey Loveday, Max Levy, et al.
The New England Journal of Medicine|September 9, 2005
Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomasMichael Cullen, Neil Steven, Lucinda Billingham, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 4, 2015
The potential of MRI-guided online adaptive re-optimisation in radiotherapy of urinary bladder cancerAnne Vestergaard, Shaista Hafeez, Ludvig P Muren, et al.
Clinical Genitourinary Cancer|August 18, 2018
Salvage Chemotherapy With Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin for Relapsed Germ Cell CancerHayley S McKenzie, Graham Mead, Robert Huddart, et al.
Oncogene|October 19, 2004
Defining minimum genomic regions of imbalance involved in testicular germ cell tumors of adolescents and adults through genome wide microarray analysis of cDNA clonesAlan McIntyre, Brenda Summersgill, Osman Jafer, et al.
Clinical and Translational Radiation Oncology|June 14, 2024
Weekly ultra-hypofractionated radiotherapy in localised prostate cancerNora Sundahl, Douglas Brand, Chris Parker, et al.
BJU International|April 27, 2020
A randomised Phase II trial of carboplatin and gemcitabine ± vandetanib in first-line treatment of patients with advanced urothelial cell cancer not suitable to receive cisplatinRobert Jones, Simon Crabb, John Chester, et al.
Pageof 12